Losmapimod Active Not Recruiting Phase 3 Trials for Primary Disease Fascioscapulohumeral Dystrophy (FSHD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05397470Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH)